Longitudinal measurements of 17α-hydroxyprogesterone in premature infants during the first three months of life

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 81, Issue 3, 1999, Pages

  Linder, N ^a,b   Davidovitch, N ^a,c   Kogan, A ^a,c   Barzilai, A ^a,b   Kuint, J ^b,c   Mazkeret, R ^a,b   Sack, J ^b,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

17 hydroxyprogesterone; Congenital adrenal hyperplasia; Postconceptional age; Steroids

Indexed keywords

HYDROXYPROGESTERONE; BIOLOGICAL MARKER; STEROID;

APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; FETUS LUNG MATURITY; HUMAN; INFANT; INTENSIVE CARE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGESTERONE RELEASE; RADIOIMMUNOASSAY; RESPIRATORY DISTRESS SYNDROME; STEROID METABOLISM; ANALYSIS OF VARIANCE; BIRTH WEIGHT; BLOOD; GESTATIONAL AGE; NEONATAL RESPIRATORY DISTRESS SYNDROME;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; STEROIDS;

EID: 0033222146     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.81.3.F175     Document Type: Article

References (18)

1. New MI. Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). Am J Mcd 1995; 9S(suppl 1A):2S8S.
2. VC'ilson JD, Foster DV, eds. Williams Texibook of Endocrinology. 8th edn. Philadelphia: VB Saunders, 1992:907-12.
3. Thompson R, Seargant L, Winter JSD. Screening for congenital adrenal hyperplasia: Distribution of 17a hydroxyprogesterone concentrations in neonatal blood spot specimens. J R-diatr 1989;114:-100-l.
4. Al Saedi S, Dean H, Dent W, Stockl E, Cronin C. Screening for congenital adrenal hjperplasia: The Déifia screening test test overestimates serum 17-hydroxyprogesterone in preterm infants. Pediatrics 1996;97:100-2.
5. Pang S, Wallace MA, Huffman L, et al. VTorldwide experience in newborn screening for classical adrenal hjperplasia due to 21- hydroxylase deficiency. Pediair 1988;81:866-74.
6. Cicognani A. The experience of neonatal screening for congenital adrenal hyperplasia. Harm Res 1992;37(suppl 3):34-8.
7. Cutfield WS, Webster D. Newborn screening for congenital adrenal hjperplasia in New Zealand. J Pcdiatr 1995;126:118-21.
8. Sack J, Front H, Kaiserman, et al. 21-hydroxylase deficiency: Screening and incidence in Israel. Harm Res 1997;48:115-19.
9. Wallace AM, Beastall GH, Cook B, et al. Neonatal screening for congenital adrenal hjperplasia: a programme based on a novel direct radioimmunoassay for 17hydroxyprogesterone in blood spots. J Endocrinol 1986;108:299-308.
10. Larsson A, Hagenfeldt L, Von Dobelin U, Curstedt T, Gustafson J, Svensson E. Neonatal screening for congenital adrenal hjperplasia using 17-hj'droxyprogesterone assay in filter paper blood spots. Harm Res 1988;30:235-40.
11. Lee MM, Rajagopalan L, Berg GJ, Moshang T. Serum adrenal steroid concentrations in premature infants. JClin Endocrinol Meiab 1989;69:1133-6.
12. Berry J, Betts P, Vood PJ. The interpretation of blood spot 17a hydroxyprogesterone levels in term and preterm neonates. Ann Clin Diochem 1986;23:546-51.
13. Ohkubo S, Shimozawa K, Matsurnoto M, Kitagawa T. Analysis of blood spot 17a hydroxyprogesterone concentration in premature infants proposal for cut-off limits in screening for congenital adrenal hyperplasia. Acta Paediatr Jpn 1992;34:126-33.
14. Dixon WJ, ed. BMDP Statistical software. Berkeley: University of California Press, 1990.
15. Alien BA, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17- hydroxyprogesterone levels. J Pediatr 1997;130:128-33.
16. Cacciari E, Balsamo A, Cassio A, et al. Neonatal screening for congenital hyperplasia. Arch Dis Child 1983;5S:803-6.
17. Knudtzon J, Markestad T, Aakvaag A, Bergsjo P. Elevated 17 hydroxyprogesterone levels in premature infantsActa Pediatr Scand 1991;SO:96-7.
18. Hingre RV, Gross SJ, Hingre KS, Mayes DM, Richman RA. Adrenal steroidogeneis in very low birth weight preterm infants. JClin Endocrinol Metab 1994;78:266-70.